Metavesco, Inc. (OTC PINK: MVCO) has announced the launch of OTC Squawk, a social network built exclusively for the over-the-counter (OTC) market. The platform, now in closed beta, provides a dedicated space for ticker-level research, due diligence, and real-time conversation among OTC traders. A waitlist is open at otcsquawk.com for users to reserve their @handle and gain access in waves.
OTC Squawk offers a comprehensive feature set tailored to OTC trading. Every supported OTC symbol has its own page displaying price data, day range and volume, price history, OTC tier and sector, a direct link to SEC EDGAR filings, top contributors, and live conversation. Traders can post in three formats: quick Squawks, Threads, and full Due Diligence write-ups, which are displayed natively on the ticker page. All posts can be tagged as bullish or bearish. The platform includes a publicly displayed reputation score called Motion, earned through consistent, high-quality participation. Transparency is a key element, with the exact formulas for feed ranking published on the platform’s “How it works” page, and default feeds cannot be purchased, ensuring no pay-to-rank system.
This launch addresses the fragmentation OTC traders have faced on general-purpose platforms, where discussions are scattered across threads. OTC Squawk consolidates ticker pages, long-form due diligence, market data, live discussion, and earned reputation into one platform designed exclusively for the OTC market. An open feedback channel allows users to contribute feature ideas that shape the platform’s future. Alongside the launch, OTC Squawk is accepting applications for its Ambassador Program at otcsquawk.com/ambassador, inviting creators, traders, and community leaders to help build the platform from its earliest days.
Separately, Metavesco expects to file its quarterly report for the quarter ended March 31, 2026, within the next ten business days and noted that work on the annual report for the year ending June 30, 2026, is already underway. The Company operates with a long-term, co-owner-aligned philosophy focused on supporting the strength, transparency, and integrity of the OTC market.
